What does Peter Neubeck invest in?

Peter Neubeck at Kurma Partners (Munich, Bayern, Germany) — sector focus: Biotech.

How do I contact Peter Neubeck?

Peter Neubeck's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.

Where is Peter Neubeck based?

Peter Neubeck is based in Munich, Bayern, Germany.

Peter Neubeck, Kurma Partners

About Peter Neubeck

Peter Neubeck, Partner at Kurma Partners, invests in early-stage (pre-seed to growth capital) biotech, medical technology, and digital health companies across Europe, with a focus on transforming academic research into therapies for severe diseases with unmet medical needs. His check sizes span the firm’s €890 million portfolio, targeting 12–15 companies per fund generation, including ~30% from academic projects. Notable portfolio companies he serves on boards include Tacalyx (oncology), Armgo Pharma, SciRhom, MedLumics, and Synendos Therapeutics, reflecting Kurma’s thesis of bridging academia and commercial healthcare innovation.

Peter Neubeck at a glance

Role: Partner
Organization: Kurma Partners
Location: Munich, Bayern, Germany
Investor type: Venture Capital
Focus areas: Biotech

Frequently asked about Peter Neubeck

What does Peter Neubeck invest in?: Peter Neubeck at Kurma Partners (Munich, Bayern, Germany) — sector focus: Biotech.
How do I contact Peter Neubeck?: Peter Neubeck's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Peter Neubeck based?: Peter Neubeck is based in Munich, Bayern, Germany.

Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Munich when building a target list.

Peter Neubeck, Kurma Partners

About Peter Neubeck

Peter Neubeck at a glance

Frequently asked about Peter Neubeck

Investors similar to Peter Neubeck (20)

Browse related investor lists (1)

Compare Peter Neubeck (8)